Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Jarid2 Restricts Long-Term Repopulating Stem Cell Capacity in Multipotent Progenitors and Acts As Tumor Suppressor in Chronic Myeloid Neoplasms

Hamza Celik, PhD, Won Kyun Koh, MS, Elizabeth Leigh Ostrander, BS, Ashley C. Kramer, BS, William C Wilson, PhD, Greg Fishberger, BS, Cates Mallaney, MS, BS, Alok Kothari, MD, Grant Anthony Challen, PhD

Blood (2017) 130 (Supplement 1): 488.

https://doi.org/10.1182/blood.V130.Suppl_1.488.488

Published: 2017

Journal Articles

The Role of JARID2 in Normal and Malignant Hematopoiesis

Hamza Celik, PhD, Kramer C Ashley, BS, Martens Andy, BS, Elizabeth Eultgen, Cates Mallaney, BS, Alok Kothari, MD, Elizabeth Ostrander, BS, Grant A. Challen, PhD

Blood (2016) 128 (22): 793.

https://doi.org/10.1182/blood.V128.22.793.793

Published: 2016

Journal Articles

Pathways for Oncogenesis in T-Cell Acute Lymphoblastic Leukemia Driven By DNA Methylation and Notch Signaling

Alok Kothari, MD, Hamza Celik, PhD, Andrew Martens, Cates Mallaney, Elizabeth L Ostrander, Elizabeth Eultgen, Grant A. Challen, PhD

Blood (2015) 126 (23): 1226.

https://doi.org/10.1182/blood.V126.23.1226.1226

Published: 2015

Journal Articles

The Role of Jarid2 in Leukemic Transformation of Chronic Myeloid Neoplasms

Hamza Celik, PhD, Andrew Martens, Cates Mallaney, Elizabeth Eultgen, Alok Kothari, MD, Gregory Fishberger, Grant A. Challen, PhD

Blood (2015) 126 (23): 1245.

https://doi.org/10.1182/blood.V126.23.1245.1245

Published: 2015

Journal Articles

Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation

Hamza Celik, Cates Mallaney, Alok Kothari, Elizabeth L. Ostrander, Elizabeth Eultgen, Andrew Martens, Christopher A. Miller, Jasreet Hundal, Jeffery M. Klco, Grant A. Challen

Blood (2015) 125 (4): 619–628.

https://doi.org/10.1182/blood-2014-08-594564

Published: 2015

Includes: Supplemental data

Journal Articles

Enforced Differentiation of Dnmt3a-Null Bone Marrow Leads to Failure with c-Kit Mutations Driving Leukemic Transformation

Hamza Celik, Cates Mallaney, Alok Kothari, Christopher A Miller, PhD, Jasreet Hundal, MS, Jeffery M. Klco, MDPhD, Grant A Challen, PhD

Blood (2014) 124 (21): 837.

https://doi.org/10.1182/blood.V124.21.837.837

Published: 2014

NARROW

Jarid2 Restricts Long-Term Repopulating Stem Cell Capacity in Multipotent Progenitors and Acts As Tumor Suppressor in Chronic Myeloid Neoplasms

The Role of JARID2 in Normal and Malignant Hematopoiesis

Pathways for Oncogenesis in T-Cell Acute Lymphoblastic Leukemia Driven By DNA Methylation and Notch Signaling

The Role of Jarid2 in Leukemic Transformation of Chronic Myeloid Neoplasms

Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation

Enforced Differentiation of Dnmt3a-Null Bone Marrow Leads to Failure with c-Kit Mutations Driving Leukemic Transformation

Email alerts

ASH Publications

American Society of Hematology

Jarid2 Restricts Long-Term Repopulating Stem Cell Capacity in Multipotent Progenitors and Acts As Tumor Suppressor in Chronic Myeloid Neoplasms

The Role of JARID2 in Normal and Malignant Hematopoiesis

Pathways for Oncogenesis in T-Cell Acute Lymphoblastic Leukemia Driven By DNA Methylation and Notch Signaling

The Role of Jarid2 in Leukemic Transformation of Chronic Myeloid Neoplasms

Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation

Enforced Differentiation of Dnmt3a-Null Bone Marrow Leads to Failure with c-Kit Mutations Driving Leukemic Transformation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only